Dr Lalchandani Labs Limited Reports Steady Performance in FY 2024-25 with Revenue of 446.13 Lakhs and Net Profit of 41.72 Lakhs
Dr Lalchandani Labs Limited, a trusted healthcare partner offering a wide spectrum of services including pathology, radiology, hospital lab management, doctor consultation, and corporate health check-ups, has reported a steady performance in FY 2024-25. The Company delivered a revenue of 446.13 Lakhs and a net profit of 41.72 Lakhs, reflecting both operational efficiency and resilience. The Indian pathology and diagnostic sector continues to show promising growth, supported by rising health awareness, an increase in lifestyle-related diseases, and digital adoption across healthcare services. The government’s emphasis on strengthening the pharma and healthcare ecosystem under flagship initiatives such as Ayushman Bharat and the National Health Mission provides significant opportunities for diagnostic laboratories. The Company is preparing itself for the future of diagnostics with focused investments in preventive healthcare, advanced molecular testing, and AI-enabled reporting.
Key Highlights
- Dr Lalchandani Labs Limited reports steady performance in FY 2024-25 with revenue of 446.13 Lakhs and net profit of 41.72 Lakhs.
- The Company has been offering world-class diagnostic lab services in New Delhi for 29 years with fully automatic machines.
- Dr Lalchandani Labs Limited is NABL accredited and employs a full-time staff of pathologists, trained technicians and quality managers with experience ranging from 5-25 years.
- The Company has 15 collection centers across Delhi/NCR and is empaneled for all major panels such as CGHS, DJB, MCD, DDA etc.
- Dr Lalchandani Labs Limited is preparing for the future of diagnostics with focused investments in preventive healthcare, advanced molecular testing, and AI-enabled reporting.